CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
available, in patients with relapsed or refractory follicular lymphoma. This will be done by comparing patients who have received a new trea...
Phase 2
London, United Kingdom and 24 other locations
with previously untreated CD20 positive Diffuse Large B-cell Lymphoma (DLBCL) requiring full course chemoimmunotherapy.All patients will rec...
Phase 2
London, United Kingdom and 32 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
London, United Kingdom and 66 other locations
on participants who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back af...
Phase 3
Romford, Essex, United Kingdom and 124 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
London, United Kingdom and 59 other locations
TrAVeRse is a multicentre, open-label, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess the rate of...
Phase 2
London, United Kingdom and 28 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
London, United Kingdom and 34 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
London, United Kingdom and 59 other locations
dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...
Phase 1, Phase 2
London, United Kingdom and 103 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
London, United Kingdom and 215 other locations
Clinical trials
Research sites
Resources
Legal